W
Wolfgang Siegert
Researcher at Charité
Publications - 86
Citations - 4441
Wolfgang Siegert is an academic researcher from Charité. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 29, co-authored 86 publications receiving 4190 citations. Previous affiliations of Wolfgang Siegert include Humboldt University of Berlin & Free University of Berlin.
Papers
More filters
Journal ArticleDOI
Guideline to reference gene selection for quantitative real-time PCR.
Aleksandar Radonic,Stefanie Thulke,Ian M. Mackay,Olfert Landt,Wolfgang Siegert,Andreas Nitsche,Andreas Nitsche +6 more
TL;DR: In this paper, quantitative real-time PCR was used to determine the mRNA transcription profiles of 13 putative reference genes, comparing their transcription in 16 different tissues and in CCRF-HSB-2 cells stimulated with 12-Otetradecanoylphorbol-13-acetate and ionomycin.
Journal ArticleDOI
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
Jörg Beyer,A Kramar,R Mandanas,Werner Linkesch,A Greinix,J. P. Droz,J L Pico,A Diehl,C Bokemeyer,H. J. Schmoll,Craig R. Nichols,Lawrence H. Einhorn,Wolfgang Siegert +12 more
TL;DR: Prognostic variables for treatment response after HDCT can be identified and the proposed prognostic model might help to optimize the use of HDCT in germ cell tumors and warrants validation in future trials.
Journal ArticleDOI
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor
Herbert G. Sayer,Matthias Kroger,Jörg Beyer,Michael G. Kiehl,Stefan Klein,K Schaefer-Eckart,Rainer Schwerdtfeger,Wolfgang Siegert,Volker Runde,Catrin Theuser,Hans Martin,Johannes Schetelig,D. W. Beelen,Axel A. Fauser,J. Kienast,K Höffken,G. Ehninger,Martin Bornhäuser +17 more
TL;DR: In this paper, the authors analyzed predictive factors for the outcome of 113 acute myeloid leukemia patients receiving reduced-intensity conditioning prior to allogeneic hematopoietic stem cell transplantation (HSCT).
Journal ArticleDOI
Subclassification of Diffuse Large B-Cell Lymphomas According to the Kiel Classification: Distinction of Centroblastic and Immunoblastic Lymphomas Is a Significant Prognostic Risk Factor
Marianne Engelhard,Günter Brittinger,Dieter Huhn,H. H. Gerhartz,Meusers P,Wolfgang Siegert,Eckhard Thiel,Wolfgang Wilmanns,U. Aydemir,Stefan Bierwolf,Henrik Griesser,Markus Tiemann,Karl Lennert +12 more
TL;DR: The diagnosis of the CB and B-IB lymphomas by the histological criteria of the Kiel classification was identified as an independent prognostic factor in diffuse large B-cell lymphomas.
Journal ArticleDOI
Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir.
T. K. Held,Stefan S. Biel,Andreas Nitsche,Andreas Kurth,S Chen,Hans R. Gelderblom,Wolfgang Siegert +6 more
TL;DR: Treatment of cidofovir with probenecid and hydration led to a significant decrease in viruria and to sustained suppression of CMV reactivation after allogeneic BMT and there were no side-effects.